Family Planning

This brief summarizes the positions, records, and potential priorities of the two major party candidates for the 2024 Presidential election on three major issues in women’s health policy – abortion, contraception, and maternal health.

The contraceptive implant is the most effective method of birth control available, and while it’s use is still low compared to other methods, its provision and use are increasing.

This factsheet provides an overview of the types of contraceptive injection, use, awareness, availability, and insurance coverage of the injection in the U.S.

This brief reviews some of the possible actions of the incoming Trump administration and new Congress based on campaign statements, policies implemented by the first Trump administration, and proposals forwarded by allied conservative think tanks and antiabortion advocacy groups.

KFF’s 2024 Women’s Health Survey finds that women aren’t fully aware that the Affordable Care Act (ACA) requires insurance plans to cover the full cost of recommended preventive health care services – especially contraception.

This brief offers a close examination of women’s experiences with contraception, insurance coverage, contraceptive preferences, and interactions with the health care system. We also explore the influence and reach of contraceptive information on social media.

In light of the new final rule regarding use of Title X federal funds for family planning clinics, Alina Salganicoff, Vice President and Director of Women’s Health Policy at KFF, answers three questions about their impact on women and the clinics that treat them.

The Trump Administration has taken numerous steps to significantly alter the Title X program, the federal grant program that supports family planning services to low-income women. This brief provides an overview of the Title X program, discusses the new 2018 funding announcement and related litigation, and reviews the Trump Administration’s proposed regulations and the implications of these changes.